1,2-distearoylphosphatidylethanolamine and betadex

1,2-distearoylphosphatidylethanolamine has been researched along with betadex in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, J; Li, C; Li, Y; Wang, C; Wei, N; Xiu, X; Zhang, L	1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and betadex

Article	Year
Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage? Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:7 Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Female; Injections, Intravenous; Kinetics; Liposomes; Male; Maximum Tolerated Dose; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Models, Chemical; Phosphatidylethanolamines; Polyethylene Glycols; Prostatic Neoplasms; Solubility; Technology, Pharmaceutical; Tumor Burden; Vincristine	2011

Article

Year

Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?

Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:7

Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Female; Injections, Intravenous; Kinetics; Liposomes; Male; Maximum Tolerated Dose; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Models, Chemical; Phosphatidylethanolamines; Polyethylene Glycols; Prostatic Neoplasms; Solubility; Technology, Pharmaceutical; Tumor Burden; Vincristine

2011